Tag: Central Drugs Standard Control Organization
Lilly launches Tanstrive tumor drug
Eli Lilly and Company India has announced the launch of Tanstrive (selpercatinib) in India, following marketing authorisation from the Central Drugs Standard Control Organization...
Lilly launches Alzheimer’s drugs in India
Eli Lilly and Company (India) has announced the launch of Lormalzi (donanemab, 350 mg/20 mL IV vial) in India, following marketing authorization from the...
Lilly’s Donanemab gets CDSCO approval
Eli Lilly and Company has announced that the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization for donanemab (350 mg/20 mL administered...
Lilly launches Mounjaro for obesity and type 2 diabetes
Eli Lilly and Company (India) have announced the launch of Mounjaro in single-dose vial presentation following the marketing authorization from the Central Drugs Standard...
Eye drops to cut need for reading glasses?
PresVu, said to be India's first eye drop for people suffering from presbyopia, is set to hit the market in October this year. The...
Again! 48 drugs fail quality test
In a fresh alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 48 medicines for failing routine quality tests.
A total of 1273 samples...
48 commonly used medicines fail quality test
Forty-eight medicines including anti-diabetic, antibiotics, calcium and cardiac drugs, have failed quality tests, the top health regulator said in a drug safety alert issued...
Bharat Biotech’s nasal vaccine to be launched on 26 January
Vaccine manufacturer Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on 26 January, Republic Day, the company’s CMD Krishna Ella announced.
The Central Drugs...